+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Chronic Cough Pipeline Drugs and Companies, 2021- Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials

  • PDF Icon

    Report

  • 70 Pages
  • November 2021
  • Region: Global
  • VPA Research
  • ID: 5463761
Chronic Cough pipeline drugs and companies, 2021- Phase, Mechanism of Action, Route, Licensing/collaboration, pre-clinical and clinical trials

The global comprehensive report on “Chronic Cough pipeline drugs and companies” presents key-decision makers with critical insights into Chronic Cough pipeline data. It provides complete analysis on pipeline drugs detailing Phases, route of administration, mechanism of action, licensing and collaborations, clinical trial details including pre-clinical phase and clinical trials.

Chronic Cough pipeline Drug Snapshot, 2021


The Chronic Cough pipeline study analyzes and monitors the development landscape with the current status of each of the pipeline drugs under development for Chronic Cough. In addition to recent status, overview of drugs is included in the study. Wide range of Chronic Cough drug related details including of company, indication, country, current status, drug alternative names, originator, orphan drug status, fast track details and others are provided.

Chronic Cough drug development pipeline by phase


The Chronic Cough pipeline study monitors the progress of new drug programs and provides analysis of phases, covering drugs from discovery to launch including discovery stage, preclinical, phase 1, phase 2, phase 3, pre-registration and other phases. The drug development stage for all Chronic Cough pipeline candidates is provided in the report enables you to understand timetable developments in Chronic Cough therapeutic area.

Chronic Cough pipeline drug Technology, Licensing and Collaboration Details


Details of technologies used for development of Chronic Cough pipeline candidates, licensing and collaboration agreements, partnership and other announcements, regulatory approval and other details are included in the Chronic Cough research study. Companies looking to partner with other players are also detailed in the report.

Chronic Cough- mechanism of action of pipeline candidates


Chronic Cough pipeline guide details the mechanism of action of each of the drug candidate under development. Further, leading types of mechanism of action (MoA) targeted by different Chronic Cough companies are identified to support decision makers target the most potential drugs under development.

Further, route of administration including oral, topical, sub-cutaneous, IV, ophthalmic and others are provided to assist researchers to understand most sought and least sought route of Chronic Cough drug administration.

Chronic Cough Drugs- Preclinical and Clinical Trials


This chapter in Chronic Cough preclinical and clinical trials assists in gaining clear understanding of the timetable developments in Chronic Cough product area. Preclinical and clinical trial details of pipeline candidates for Chronic Cough are detailed in the report. Details including participants, duration, companies, locations and others are provided for the trials.

Chronic Cough companies and Profiles


Companies developing Chronic Cough pipeline products are analyzed in the industry report, presenting details of business overview, location, and year of establishment, contacts, key employees, and a brief business profile.

Chronic Cough Market Developments


The report presents the recent news and developments in the Chronic Cough pipeline industry. Progress of candidates, mergers, acquisitions, asset transactions, licensing, collaborations, partnership and joint ventures, regulatory approvals, marketing and other relevant news and deals are discussed in the report.

Reasons to Buy

  • Make better-informed decisions based on the current status of each of the pipeline drug candidate
  • Identify new business opportunities by evaluating the progress of the Chronic Cough R&D pipeline
  • Analyze the market and research segments based on a comprehensive analysis of Chronic Cough pipeline drugs and clinical trials
  • Identify Chronic Cough drug pipeline trends based on consistently delivered hands on pipeline and clinical trials information
  • Gain clear understanding of the Chronic Cough drugs through our expert coverage and in-depth analysis of drugs, companies and market trends
  • Check the Chronic Cough pipeline progress of target companies and key strategies of leading players
  • Gain real-time insights into the global Chronic Cough pipeline news, developments and insights

Scope of the Report

  • Disease overview including Chronic Cough symptoms, widely used treatment options, companies and other details are included
  • Chronic Cough Pipeline Summary including the dominant phase type, number of drug candidates progressing to advanced phases, early stage pipeline candidates, leading companies, dominant route of mechanism and route of administration and other details are provided.
  • Chronic Cough pipeline drug count by phase, company and mechanism of action
  • Chronic Cough companies investing R&D resources in pipeline
  • Dominant Mechanism of Action
  • Most researched route of administration
  • For each pipeline candidate, drug, originator, co-developers, other companies, special status, phase, synonym, current status and other details are included
  • Clinical trial information for each Chronic Cough pipeline candidate are provided including preclinical, phase 1, phase 2 and phase 3 details
  • Chronic Cough companies including their business snapshot, business description and Chronic Cough pipelines are included.
  • Recent Chronic Cough market developments, pipeline news and deals are provided

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Executive Summary
2.1 Chronic Cough Disease overview
2.2 Companies investing in Chronic Cough industry
3 Chronic Cough Pipeline Snapshot, 2021
3.1 Chronic Cough Pipeline Drugs- Dominant phase type
3.2 Chronic Cough pipeline Drugs- Leading Mechanism of Action
3.3 Chronic Cough Pipeline Drugs- Widely researched Route of Administration
3.4 Chronic Cough Pipeline- New Molecular Entity
3.5 Chronic Cough pipeline- Companies, Universities and Institutes
4. Chronic Cough Drug Profiles
4.1 Current Status of Chronic Cough Drug Candidates, 2021
4.2 Chronic Cough Drugs in Development- Originator/Licensor
4.3 Chronic Cough Drugs in Development- Route of Administration
4.4 Chronic Cough Drugs in Development- New Molecular Entity (NME)
5. Chronic Cough Clinical Trials
5.1 Preclinical Trial details
5.2 Phase 1 Clinical Trial Details
5.3 Phase 2 Clinical Trial Details
5.4 Phase 3 Clinical Trial Details
6. Chronic Cough Companies and Universities
6.1 Leading Chronic Cough companies researching in drug development
6.2 Leading Chronic Cough Universities/Institutes investing in drug development
7. Chronic Cough News and Deals
7.1 Recent Chronic Cough Market Developments
7.2 Pipeline Drug News Updates
7.3 Pipeline Company updates
8. Appendix
8.1 Sources and Research Methodology
8.2 Online Database
8.3 Primary and Secondary Methodology
8.4 Customization options
8.5 Contact